These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13379520)

  • 81. [Effect of rythromycin on the growth of "dissociated resistant" Staph. aureus in bacteriostasis from another macrolide or a related antibiotic].
    Bourse R; Monnier J
    Ann Inst Pasteur (Paris); 1967 Jul; 113(1):67-79. PubMed ID: 6079710
    [No Abstract]   [Full Text] [Related]  

  • 82. Vancomycin, a new antibiotic. II. In vitro antibacterial studies.
    MCGUIRE JM; WOLFE RN; ZIEGLER DW
    Antibiot Annu; 1955-1956; 3():612-8. PubMed ID: 13355337
    [No Abstract]   [Full Text] [Related]  

  • 83. [DEVELOPMENT OF STAPHYLOCOCCAL RESISTANCE AND CROSS-RESISTANCE TO OLEANDOMYCIN AND SEKAZIN].
    BASS TM
    Antibiotiki; 1963 Dec; 8():1109-12. PubMed ID: 14172769
    [No Abstract]   [Full Text] [Related]  

  • 84. The in vitro antibiotic activity of novobiocin on M. pyogenes and some intestinal gram-negative bacteria.
    COPPO A
    Antibiot Chemother (Northfield); 1957 Jun; 7(6):297-305. PubMed ID: 24544434
    [No Abstract]   [Full Text] [Related]  

  • 85. [Bacteriology and epidemiology of staphylococcal resistance].
    WARNECKE B; WERNICKE HH
    Munch Med Wochenschr; 1956 Sep; 98(38):1274-7. PubMed ID: 13378428
    [No Abstract]   [Full Text] [Related]  

  • 86. Role of glycosylation and deglycosylation in biosynthesis of and resistance to oleandomycin in the producer organism, Streptomyces antibioticus.
    Vilches C; Hernandez C; Mendez C; Salas JA
    J Bacteriol; 1992 Jan; 174(1):161-5. PubMed ID: 1530845
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Effect of antibiotics on variability of Staphylococcus].
    MOROZ AF
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Jan; 27(1):22-6. PubMed ID: 13325876
    [No Abstract]   [Full Text] [Related]  

  • 88. [Synergism and antagonism of antibiotics; experimental research with Staphylococcus pyogenes aureus of Oxford].
    LENTI G; ODDONE I; FAZIO M; CALCIATI A; JONA E
    G Batteriol Immunol; 1955; 48(5-6):224-38. PubMed ID: 13277778
    [No Abstract]   [Full Text] [Related]  

  • 89. The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis.
    Juda M; Chudzik-Rzad B; Malm A
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):155-60. PubMed ID: 27008373
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Cross-resistance of bacteria and its relation to microbial sensitivity changes to various drugs].
    MOROZ AF; KOSTIUKOVSKAIA OM
    Antibiotiki (Mosc); 1958; 3(4):51-7. PubMed ID: 24545069
    [No Abstract]   [Full Text] [Related]  

  • 91. Selection of stable multiple antibiotic-resistant variants of Micrococcus pyogenes in the absence of antibiotics.
    FUSILLO MH
    Antibiot Chemother (Northfield); 1956 Feb; 6(2):125-9. PubMed ID: 24543914
    [No Abstract]   [Full Text] [Related]  

  • 92. Recent changes in sensitivity of Micrococcus pyogenes to various antibiotic agents.
    NEEDHAM GM; NICHOLS DR
    J Lab Clin Med; 1953 Jan; 41(1):150-6. PubMed ID: 13023106
    [No Abstract]   [Full Text] [Related]  

  • 93. Drug resistance to staphylococci. 3. Resistance to some macrolide antibiotics and inducible system.
    Kono M; Hashimoto H; Mitsuhashi S
    Jpn J Microbiol; 1966 Apr; 10(1):59-66. PubMed ID: 5297542
    [No Abstract]   [Full Text] [Related]  

  • 94. Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes.
    Menninger JR; Otto DP
    Antimicrob Agents Chemother; 1982 May; 21(5):811-8. PubMed ID: 6179465
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Studies on the in vitro sensitivity of strains of Micrococcus pyogenes var. aureus to tetracycline, oleandomycin and mixtures of tetracycline and oleandomycin].
    PRZYBYLKIEWICZ Z; ZGORNIAK-NOWOSIELSKA I
    Pol Tyg Lek; 1959 Dec; 14():2143-5. PubMed ID: 14435191
    [No Abstract]   [Full Text] [Related]  

  • 96. Separation and determination of the macrolide antibiotics (erythromycin, spiramycin and oleandomycin) by capillary electrophoresis coupled with fast reductive voltammetric detection.
    Zhou J; Chen Y; Cassidy R
    Electrophoresis; 2000 Apr; 21(7):1349-53. PubMed ID: 10826680
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics.
    Niitu Y; Hasegawa S; Suetake T; Kubota H; Komatsu S; Horikawa M
    J Pediatr; 1970 Mar; 76(3):438-43. PubMed ID: 5413664
    [No Abstract]   [Full Text] [Related]  

  • 98. Erythromycin sensitivity of Micrococcus pyogenes var. aureus in a hospital population (development of resistance).
    GRIGSBY ME; CHAPPELLE E; PEACOCK T
    Antibiot Chemother (Northfield); 1955 Jun; 5(6):350-2. PubMed ID: 24543667
    [No Abstract]   [Full Text] [Related]  

  • 99. Observations on bacteriostatic and bactericidal action of erythromycin.
    UNGER L; KISCH A
    Proc Soc Exp Biol Med; 1958 May; 98(1):176-8. PubMed ID: 13554582
    [No Abstract]   [Full Text] [Related]  

  • 100. In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae.
    Nitu Y; Hasegawa S; Kubota H
    Antimicrob Agents Chemother; 1974 May; 5(5):513-9. PubMed ID: 4462466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.